LEXISCAN (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the LEXISCAN drug offered from Astellas Pharma US, Inc.. This Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
| NON-PROPRIETARY NAME: | regadenoson |
| SUBSTANCE NAME: | REGADENOSON |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-04-10 |
| END MARKETING DATE: | 0000-00-00 |
LEXISCAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | LEXISCAN from Astellas Pharma US, Inc. |
| LABELER NAME: | Astellas Pharma US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.08(mg/mL) |
| START MARKETING DATE: | 2008-04-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0469-6501_c66f773a-3cee-4175-aff5-ad5185641ec3 |
| PRODUCT NDC: | 0469-6501 |
| APPLICATION NUMBER: | NDA022161 |
Other REGADENOSON Pharmaceutical Manufacturers / Labelers:
